Malaria is one of the deadliest diseases worldwide. In 2021, the first approved malaria vaccine came to fruition, but its effectiveness remains low. New, more effective malaria vaccines are now in clinical trials, indicating that effective malaria prevention may soon be within reach. In this webinar, experts will discuss critical developments toward the next malaria vaccine.
Topics to be covered
Speakers
Stephen L. Hoffman, MD, DSc (hon)
Chief Executive and Scientific Officer
Sanaria Inc.
Stephanie Yanow, PhD
Professor in Global Health
School of Public Health
University of Alberta
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2025 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy